Chiglitazar prevents diabetes-induced skeletal muscle loss by enhancing myogenic differentiation through the MEK/ERK pathway.

Bilessglu (chiglitazar) - Chipscreen

http://www.ncbi.nlm.nih.gov/pubmed/42035619

Bei Jiang; Fengping Xu; Qiu Li; Wenting Song; Xiaohui Wang; Yanxin Dong; Yuxin Zhou

Apr 27, 2026